Rate My Professor Erika Bosio

Bosio completed her PhD in Immunology at UWA in 2002, titled "Low dose orally administered type I Interferon therapy: Murine Studies," following a BSc (Hons) in Microbiology/Molecular Biology from UWA in 1997. After her PhD, she spent six years in Italy as a postdoctoral scientist working on xenotransplantation research projects and clinical studies investigating antibody-mediated rejection, particularly assessing neonatal porcine islets as an alternative source for type 1 diabetes transplantation. Returning to Australia, she joined the Centre for Diabetes Research, focusing on human embryonic stem cells as islet progenitor sources. After a career interruption for maternity and parental reasons from 2011 to 2014, she returned part-time before taking up her CCREM role. Her research interests include sepsis, anaphylaxis, stroke, biomarker analyses, immunology, emergency medicine, critical illness, and disease mechanisms. Current projects aim to understand immune responses in critical illness via protein, genetic, and metabolomic biomarkers, with national and international collaborations including Harvard, University College London, and the University of British Columbia. She is developing an innovative 3D-multilayered living model of the microvasculature in collaboration with UWA bioengineers and physiologists at the Harry Perkins Institute. Bosio has published 13 peer-reviewed articles, supported four PhD completions, obtained $300,000 in grant funding for CCREM, and contributes to an NHMRC Centre of Research Excellence grant of $381,455 for Translational Venom and Antivenom Research. She was awarded the Sophie Lewis Fellowship by the Australasian College for Emergency Medicine (2017-2020) and has served as a grant reviewer for NHMRC, Diabetes Australia, and the Queensland Emergency Medicine Foundation.